GM

Ganesh Mahadevam

Director Director DIN 02791232
DIN 02791232 First appointment Nov 2009 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Nov 2009
Shareholding value •••• Premium profile

About Ganesh Mahadevam

Data last updated:

Ganesh Mahadevam was a Director at Zenoks Biotech Private Limited (2010–2023) and Director at Axis Wellness Private Limited (2009–2023). The companies operate in Pharma.

DIN 02791232
Primary Designation Director
Industry Pharma
First Appointment 26 Nov 2009

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zenoks Biotech Private Limited U24230GJ2010PTC060795
Director18 May 20102010₹2.83 Cr (FY 2024)Active
Axis Wellness Private Limited U24230GJ2009PTC058711
Director26 Nov 20092009Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Zenoks Biotech Private Limited
Axis Wellness Private Limited
Premium access

Shareholding and investment profile for Ganesh Mahadevam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ganesh Mahadevam

Ganesh Mahadevam was first appointed on 26 Nov 2009 as Director at Axis Wellness Private Limited. The most recent appointment on record is 18 May 2010 at Zenoks Biotech Private Limited.

Ganesh Mahadevam held 2 earlier board appointments: Zenoks Biotech Private Limited (Director, 18 May 2010 to 29 Dec 2023); Axis Wellness Private Limited (Director, 26 Nov 2009 to 29 Dec 2023).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available